We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Guideline on Handling Endobronchial Ultrasound Transbronchial Needle Samples

By MedImaging International staff writers
Posted on 21 Oct 2024
Image: CHEST has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration specimen processing and handling (Photo courtesy of CHEST)
Image: CHEST has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration specimen processing and handling (Photo courtesy of CHEST)

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard procedure for the initial diagnosis and staging of lung cancer; however, there is limited guidance on how to handle and process specimens during and after acquisition to enhance both diagnostic yield and specimen preservation for subsequent ancillary testing. Given the significant variation in sample collection practices among different institutions, a new clinical guideline on EBUS-TBNA now aims to utilize the experiences of both pulmonologists and pathologists to standardize the process.

The strength of evidence regarding the handling and processing of EBUS-TBNA specimens varies, but there is sufficient information in some areas to assist clinicians with specific aspects of specimen handling. The American College of Chest Physicians (CHEST, Glenview, IL, USA) has published a new clinical guideline on EBUS-TBNA, which strongly recommends performing four or more needle passes instead of three or fewer in patients suspected of having malignant disease undergoing EBUS-TBNA. The guideline also advises utilizing rapid on-site evaluation rather than standard care for patients with suspected malignancies undergoing EBUS-TBNA. Furthermore, for patients suspected of having malignant disease, the guideline recommends using a smaller needle (21 gauge or 22 gauge) instead of a larger one (19 gauge). The complete list of recommendations outlined in the new guideline can be accessed through the CHEST journal website.

Related Links:
CHEST

Ultrasound Needle Guidance System
SonoSite L25
MRI System
nanoScan MRI 3T/7T
X-Ray Illuminator
X-Ray Viewbox Illuminators
Mammography System (Analog)
MAM VENUS

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.